
About
Physical Characteristics
Caps:
Ovada a campanulada, de 1-3 cm de ancho, de color amarillo claro, se vuelve azul oscuro al tocarla.
Gills:
Adnato, inicialmente grisáceo, volviéndose negro violáceo con la edad
Psychoactive Effects
EufóRico
Describiendo sentimientos intensos de felicidad o emoción
Perceptual
El cambio en la forma en que se perciben las cosas, incluyendo cambios en la percepción del tiempo, la percepción espacial y la percepción del propio cuerpo.
Visuales
Las especies TTBVI y Pan Cyan tienen la reputación de hacer ver patrones, formas y objetos intensamente vívidos y coloridos. Se suele encontrar que TTBVI es más potente que el Pan Cyan general y, por lo tanto, puede inducir una experiencia más intensa.
Helps With
Depresión
Alivia los síntomas de la depresión, mejorando el estado de ánimo y la perspectiva.
Ansiedad
Ayuda a aliviar sentimientos de preocupación, miedo e inquietud
Adicción
Ayuda a superar la adicción y el abuso de sustancias
TEPT
Ayuda a aliviar los síntomas del trastorno de estrés postraumático
TOC
Ayuda a aliviar los síntomas del trastorno obsesivo-compulsivo
TDA TDAH
Ayuda a aliviar los síntomas del trastorno por déficit de atención y del trastorno por déficit de atención con hiperactividad.
Dolor
Se ha demostrado que la microdosificación de psilocibina ayuda con ciertos tipos de dolor.
Migrañas
La investigación muestra que la psilocibina, el compuesto activo en los hongos alucinógenos, tiene potenciales beneficios terapéuticos para las migrañas. Un estudio a pequeña escala realizado por la Escuela de Medicina de Yale encontró que una sola dosis de psilocibina redujo la probabilidad de sufrir un ataque de migraña en dos semanas.
Possible Side Effects
Náusea
Una sensación de malestar en el estómago con ganas de vomitar
Medicinal Chemistry
Similar Species

Species: Panaeolus foenisecii
Edibility: Psicoactivo
Key Differences: P. foenisecii carece del característico moretón azul y del color amarillo claro del sombrero de la cepa BVI.

Species: Panaeolus foenisecii
Edibility: Psicoactivo
Mushroom Ratings
4.0
Based on 2 Reviews
5
★4
★3
★2
★1
★Share your thoughts
If you've consumed this mushroom, share your thoughts with our community
01/29/2025
Anonymous
01/29/2025
Thomas Folbrecht
1 person found this helpful
References
The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin
Psilocybin desynchronizes the human brain
An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus
Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
Interest in psychedelic research in the West is surging, however, clinical trials have almost exclusively studied synthetic compounds such as MDMA, ketamine, DMT, LSD, ibogaine, and psilocybin. To date, few clinical trials have utilized whole mushroom/plant material like Psilocybe mushrooms, Iboga, or Ayahuasca. Individuals participating in the Roots To Thrive Psilocybin-Assisted Therapy for End of Life Distress program were administered synthetic psilocybin, whole Psilocybe cubensis, and mycological extract on separate occasions and post-treatment interview transcripts were qualitatively analyzed to discern themes and patterns. There was broad consensus that all three forms were helpful and similar, all generating visual and perceptual distortions, emotional and cognitive insight, and mystical experiences. However, synthetic psilocybin was said to feel less natural compared to organic forms, and the overall quality of experience of synthetic psilocybin was inferior to the organic forms. Research should be conducted with whole psychedelic mushrooms and extract in addition to synthetic psilocybin given this preliminary data, especially when considering that medicine keepers around the world have utilized whole mushrooms and plant material for millennia.
2024
Healthy adults were tracked before, during and for 3 weeks after high-dose psilocybin (25 mg) and methylphenidate (40 mg), and brought back for an additional psilocybin dose 6–12 months later. Psilocybin massively disrupted functional connectivity (FC) in cortex and subcortex, acutely causing more than threefold greater change than methylphenidate. These FC changes were driven by brain desynchronization across spatial scales (areal, global), which dissolved network distinctions by reducing correlations within and anticorrelations between networks. Psilocybin-driven FC changes were strongest in the default mode network, which is connected to the anterior hippocampus and is thought to create our sense of space, time and self.
2024
This review discusses species identification, taxonomy and classification, available DNA sequence data and psychedelic species in Psilocybe, Panaeolus, Pluteus, and Gymnopilus, as well as similar looking genera that could be harmful.
2023
This study examines the effects and safety of Panaeolus cyanescens extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.
2020
Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer.
2010